Clinical Trials Browser

Phase 1 × vorasidenib × CNS × Clear all

NCT05484622 2026-03-12

Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma

Phase 1 Active not recruiting

Astrocytoma, Oligodendroglioma

NCT05609994 2025-07-18

ViCToRy

Phase 1 Recruiting

Brain Neoplasms, Glioma